taurine has been researched along with Apoplexy in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine promoted axonal sprouting via Shh-mediated mitochondrial improvement in ischemic stroke." | 8.31 | Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke. ( He, J; He, W; Jia, J; Ma, G; Tian, X, 2023) |
| "Taurine (2-aminoethansulfolic amino acid) exerts neuroprotective actions in experimental stroke." | 7.88 | Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. ( Jin, R; Li, G; Liu, S; Wang, M; Xiao, AY, 2018) |
| " Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls." | 7.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
| "Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 7.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
| "The dose-dependent protection of taurine against experimental stroke has been demonstrated previously." | 7.78 | Therapeutic window of taurine against experimental stroke in rats. ( Gu, Y; Sun, M; Xu, C; Zhao, YM, 2012) |
| "Post-transcriptional taurine modification at the first anticodon ("wobble") nucleotide is deficient in A3243G-mutant mitochondrial (mt) tRNA(Leu(UUR)) of patients with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)." | 7.78 | Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. ( Ichimiya, H; Kamimura, N; Nishimaki, K; Nishimatsu, S; Ohsawa, Y; Ohta, S; Rikimaru, M; Sunada, Y; Wolf, AM, 2012) |
| "Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system." | 5.39 | The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. ( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013) |
| "Taurine (T) was first noted as beneficial for stroke and cardiovascular diseases (CVD) prevention in genetic rat models, stroke-prone spontaneously hypertensive rats (SHRSP)." | 4.86 | Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. ( Hamada, A; Kunimasa, K; Mori, H; Mori, M; Taguchi, T; Yamori, Y, 2010) |
| "In MELAS, taurine modification defect in the anticodon of mitochondrial leucine tRNA causes codon translation failure." | 4.31 | [Therapeutics for Mitochondrial Encephalomyopathy]. ( Sunada, Y, 2023) |
| "Taurine promoted axonal sprouting via Shh-mediated mitochondrial improvement in ischemic stroke." | 4.31 | Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke. ( He, J; He, W; Jia, J; Ma, G; Tian, X, 2023) |
| "To investigate the association of the Japanese diet with risks for lifestyle-related diseases, the biomarkers of seafood and soybean consumption, taurine (T) and soy isoflavones (I), and others were analyzed in 24-hour urine (24U) samples collected from participants of the Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study coordinated by the World Health Organization (WHO)." | 4.12 | Grading of Japanese Diet Intakes by 24-Hour Urine Analysis of Taurine and Soy Isoflavones in Relation to Cardiovascular Risks. ( Mori, H; Mori, M; Sagara, M; Yamori, Y, 2022) |
| "Taurine (2-aminoethansulfolic amino acid) exerts neuroprotective actions in experimental stroke." | 3.88 | Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. ( Jin, R; Li, G; Liu, S; Wang, M; Xiao, AY, 2018) |
| "Emerging evidence has suggested that hydrogen sulfide (H2S) may alleviate the cellular damage associated with cerebral ischemia/reperfusion (I/R) injury." | 3.85 | The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model. ( Choi, CG; Choi, Y; Ha, HK; Ham, SJ; Jeon, SB; Jung, SC; Kim, J; Kim, JK; Kim, KW; Kim, ST; Kwon, JI; Shim, WH; Sung, YS; Woo, CW; Woo, DC, 2017) |
| " Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls." | 3.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
| "Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 3.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
| "The dose-dependent protection of taurine against experimental stroke has been demonstrated previously." | 3.78 | Therapeutic window of taurine against experimental stroke in rats. ( Gu, Y; Sun, M; Xu, C; Zhao, YM, 2012) |
| "Post-transcriptional taurine modification at the first anticodon ("wobble") nucleotide is deficient in A3243G-mutant mitochondrial (mt) tRNA(Leu(UUR)) of patients with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)." | 3.78 | Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. ( Ichimiya, H; Kamimura, N; Nishimaki, K; Nishimatsu, S; Ohsawa, Y; Ohta, S; Rikimaru, M; Sunada, Y; Wolf, AM, 2012) |
| " Stroke mortality was associated positively with Na and Na/K ratio and phospholipid arachidonic acid (AA), and negatively with TC and K." | 3.73 | Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. ( Ikeda, K; Liu, L; Mizushima, S; Nara, Y; Yamori, Y, 2006) |
| "Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system." | 1.39 | The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. ( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013) |
| "We introduced intracerebral hemorrhage in each of eight anesthetized New Zealand rabbits by injecting 0." | 1.32 | Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. ( Ali, Z; Baker, G; Guterman, LR; Hopkins, LN; Qureshi, AI; Shuaib, A; Suri, MF; Todd, K, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, M | 2 |
| Sagara, M | 1 |
| Mori, H | 2 |
| Yamori, Y | 3 |
| Sunada, Y | 3 |
| Jia, J | 1 |
| Tian, X | 1 |
| He, J | 1 |
| Ma, G | 1 |
| He, W | 1 |
| Woo, CW | 1 |
| Kwon, JI | 1 |
| Kim, KW | 1 |
| Kim, JK | 1 |
| Jeon, SB | 1 |
| Jung, SC | 1 |
| Choi, CG | 1 |
| Kim, ST | 1 |
| Kim, J | 1 |
| Ham, SJ | 1 |
| Shim, WH | 1 |
| Sung, YS | 1 |
| Ha, HK | 1 |
| Choi, Y | 1 |
| Woo, DC | 1 |
| Ohsawa, Y | 2 |
| Hagiwara, H | 1 |
| Nishimatsu, SI | 1 |
| Hirakawa, A | 1 |
| Kamimura, N | 2 |
| Ohtsubo, H | 1 |
| Fukai, Y | 1 |
| Murakami, T | 1 |
| Koga, Y | 1 |
| Goto, YI | 1 |
| Ohta, S | 2 |
| Jin, R | 1 |
| Xiao, AY | 1 |
| Liu, S | 1 |
| Wang, M | 1 |
| Li, G | 1 |
| Windpessl, M | 1 |
| Müller, P | 1 |
| Wu, S | 1 |
| Yue, Y | 1 |
| Tian, H | 1 |
| Tao, L | 1 |
| Wang, Y | 1 |
| Xiang, J | 1 |
| Wang, S | 1 |
| Ding, H | 1 |
| Wu, F | 1 |
| Koenig, KL | 1 |
| Zeleniuch-Jacquotte, A | 1 |
| Jonas, S | 1 |
| Afanasyeva, Y | 1 |
| Wójcik, OP | 1 |
| Costa, M | 1 |
| Chen, Y | 1 |
| Taguchi, T | 1 |
| Hamada, A | 1 |
| Kunimasa, K | 1 |
| Sun, M | 3 |
| Gu, Y | 3 |
| Zhao, Y | 2 |
| Xu, C | 3 |
| Ghandforoush-Sattari, M | 1 |
| Mashayekhi, SO | 1 |
| Nemati, M | 1 |
| Ayromlou, H | 1 |
| Zhao, YM | 1 |
| Tu, J | 1 |
| A, J | 1 |
| Wang, G | 1 |
| Wen, H | 1 |
| Wang, A | 1 |
| Di, L | 1 |
| Cao, B | 1 |
| Liu, L | 2 |
| Rikimaru, M | 1 |
| Wolf, AM | 1 |
| Nishimaki, K | 1 |
| Ichimiya, H | 1 |
| Nishimatsu, S | 1 |
| Gharibani, PM | 1 |
| Modi, J | 1 |
| Pan, C | 1 |
| Menzie, J | 1 |
| Ma, Z | 1 |
| Chen, PC | 1 |
| Tao, R | 1 |
| Prentice, H | 1 |
| Wu, JY | 1 |
| Qureshi, AI | 1 |
| Ali, Z | 1 |
| Suri, MF | 1 |
| Shuaib, A | 1 |
| Baker, G | 1 |
| Todd, K | 1 |
| Guterman, LR | 1 |
| Hopkins, LN | 1 |
| Mizushima, S | 1 |
| Ikeda, K | 1 |
| Nara, Y | 1 |
1 review available for taurine and Apoplexy
| Article | Year |
|---|---|
Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Cholesterol, Dietary; Diet; Dietary Fats; Humans; | 2010 |
1 trial available for taurine and Apoplexy
| Article | Year |
|---|---|
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial.
Topics: Administration, Oral; Adolescent; Adult; Dietary Supplements; Female; Humans; Male; MELAS Syndrome; | 2019 |
17 other studies available for taurine and Apoplexy
| Article | Year |
|---|---|
Grading of Japanese Diet Intakes by 24-Hour Urine Analysis of Taurine and Soy Isoflavones in Relation to Cardiovascular Risks.
Topics: Cardiovascular Diseases; Diet; Heart Disease Risk Factors; Humans; Isoflavones; Japan; Risk Factors; | 2022 |
[Therapeutics for Mitochondrial Encephalomyopathy].
Topics: Arginine; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine | 2023 |
Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke.
Topics: Adenosine Triphosphate; Animals; DNA, Mitochondrial; Hedgehog Proteins; Ischemic Stroke; Mice; Mitoc | 2023 |
The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model.
Topics: Animals; Apoptosis; Aspartic Acid; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Humans; Hy | 2017 |
Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracrani | 2018 |
Valproic acid and MELAS: a word of warning.
Topics: Female; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine | 2013 |
Tramiprosate protects neurons against ischemic stroke by disrupting the interaction between PSD95 and nNOS.
Topics: Animals; Apoptosis; Brain Ischemia; Disks Large Homolog 4 Protein; Intracellular Signaling Peptides | 2014 |
Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antioxidants; Bile Acids and Salts; Blood Pressure; Case-Cont | 2016 |
Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats.
Topics: Adenosine Triphosphate; Animals; bcl-2-Associated X Protein; bcl-X Protein; Brain Ischemia; Calpain; | 2011 |
Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Disease Models, Animal; Gene Expression Regula | 2012 |
Changes in plasma concentration of taurine in stroke.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Pressure; Chromatography, High Pres | 2011 |
Therapeutic window of taurine against experimental stroke in rats.
Topics: Animals; Male; Rats; Rats, Sprague-Dawley; Stroke; Taurine | 2012 |
[Plasma metabonomics study of ischemic cerebral apoplexy rats treated with Tongsaimai pellets].
Topics: Animals; Brain Ischemia; Drugs, Chinese Herbal; Fructose; Glyceric Acids; Hydroxyproline; Lactic Aci | 2012 |
Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS.
Topics: Adult; Cells, Cultured; Female; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine; Young Adult | 2012 |
The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Topics: Activating Transcription Factor 6; Animals; Apoptosis; Brain Ischemia; Caspase 12; Caspase 3; Cell S | 2013 |
Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study.
Topics: Analysis of Variance; Animals; Asparagine; Aspartic Acid; Brain Ischemia; Cerebral Hemorrhage; Chrom | 2003 |
Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries.
Topics: Age Factors; Aged; Americas; Analysis of Variance; Arachidonic Acid; Asia; Australia; Biomarkers; Ch | 2006 |